← FDA DRUG APPROVALS

FDA ANDA · ANDA065247

CEFAZOLIN SODIUM

Sponsor: HOSPIRA INC

APPLICATION
ANDA065247
TYPE
ANDA
ORIGINAL APPROVAL
2005-08-12
LATEST ACTION
2013-01-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2013-01-17Labeling · Supplement 11LabelAP
2011-08-31Labeling · Supplement 10AP
2010-06-30Labeling · Supplement 6AP
2005-08-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →